BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KESHO - ECPv6.16.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://kesho-kenya.org
X-WR-CALDESC:Events for KESHO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Nairobi
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:EAT
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20230713T183000
DTEND;TZID=Africa/Nairobi:20230713T210000
DTSTAMP:20240215T102055Z
CREATED:20230705T115719Z
LAST-MODIFIED:20240215T102055Z
UID:8568-1689273000-1689282000@kesho-kenya.org
SUMMARY:Treatment of Lung Cancer with EGFR Mutations
DESCRIPTION:[vc_row][vc_column]    	    	\n            \n            	            \n            \n                            \n            \n        \n        	    \n    	\n                	 SPEAKER PROFILES:                \n        \n    \n    [vc_column_text] \nProf Shahin Sayed\nShahin Sayed is Associate Professor & Consultant in Anatomical Pathology and Cytology\, in the Department of Pathology\, Medical College\, Aga Khan University and the current Chair and Laboratory Director of Pathology at AKUH\, Nairobi. \nDr Sayed graduated from the University of Nairobi with a Bachelor of Medicine and Surgery degree. She holds a Master of Medicine in General Pathology from the University of Nairobi where she was awarded the best student in Pathology prize. She is a Fellow of the Royal College of Pathologists\, United Kingdom and a Fellow of the College of Pathologists of East Central and Southern Africa. \nDr. Sayed is the Secretary General of the College of Pathologists of East Central and Southern Africa\, Chair of the Academic Committee of the Senate – East Central and Southern African (ECSA) College of Health Sciences\, Chair of theBoard of Directors of African Strategies for Advancing Pathology (ASAP\, co-chair Technical Working Group (TWG) on Diagnostics for the Cancer Control Programme – Ministry of Health\, Kenya (MoH). \nShe is also a steering committee member and Commissioner for the Lancet Commission on Diagnostics and a member of the Lancet Oncology Commission for Sub-Saharan Africa. She has also been a recent member of the WHO-SAGE IVD Committee (2019-2020). Dr. Sayed is a member of the United States and Canadian Academy of Pathology (USCAP) and the American Society of Clinical Oncology (ASCO). \nDr. Sayed is in charge of the breast service at AKUHN. Her research interest span oncopathology with a special focus in breast cancer and solid haematolymphoid malignancies. She has several grants and peer reviewed publications in her area of research interest. She has also led research initiatives and interventions that have developed a sustainable model of community-based engagement to improve breast cancer screening and diagnosis. \nDr Andrew Odhiambo\nAndrew Odhiambo is a Consultant Physician/Medical Oncologist & Program Director/Lecturer (Medical Oncology Fellowship Program) at the University of Nairobi. Dr. Andrew holds a Master’s degree in Internal Medicine from the University of Nairobi. He has attended preceptorship training in Haematological Oncology & Infectious Diseases from the University of Maryland Marleen & Stewart Greenbaum Cancer Centre in the United States. He later did his Fellowship in Medical Oncology in the United Kingdom and was certified by the Federation of Royal College of Physicians of the United Kingdom as well as the Association of Cancer Physicians and the European Society for Medical Oncology. He is also a Fellow of the Royal College of Physicians of Edinburgh as well as the East\, Central & Southern Africa College of Physicians. \nHe is the outgoing Secretary & former Treasurer of Kenya Society of Haematology & Oncology (KESHO). Dr. Andrew is a member of KAP\, ASCO\, ESMO\, AORTIC & ECSACOP. Dr. Andrew serves as an expert advisor for local and international bodies i.e. MOH\, Kenya Cancer Prevention TWG\, ASCO & NCCN Cancer Treatment Guidelines Committees. He has published several articles on cancer in both international and local peer reviewed scientific journals. \nDr. Andrew was awarded the prestigious Business Daily Africa Top 40 under 40 men in the year 2017. He is passionate about cancer education and awareness especially through digital platforms. He has over 50 appearances in mainstream local and international TV and print media promoting cancer awareness. \nHis key areas of sub specialization and interest include Colon cancer\, Stomach cancer\, Breast Cancer\, Pancreatic\, Liver & Bile Duct cancer\, Cancer or Unknown Primary\, Lymphoma as well as newer treatments i.e. Immunotherapy & Targeted therapy for Colon\, Skin\, Lung\, Kidney cancers etc. For his full profile\, please visit www.drandrewodhiambo.com \nProf Mohsen Mokhtar\nMohsen Mokhtar is a Professor of Clinical Oncology in Al-Kasr Al-Aini Medical School and Cairo University\, Cairo Egypt. Prof Mokhtar assisted in developing the syllabus and course structure at Al-Kasr Al-Aini\, as well as\, supervised several research programs and theses. \nProf Mokhtar is the managing Director of Cairo University Center of Oncology and Nuclear Medicine NEMROCK and the President of CANSURVIVE. \nProf Mokhtar has published more than 50 articles in several regional magazines in topics including: breast\, lung\, pediatric\, colorectal\, ovarian malignancies NHL and hematologic malignancies. Professionally\, he has more than 20 years of experience in hospital management. He is currently the chief medical director in Elaj group covering the clinical and medical audit of group facilities. \nDr Njoki Njiraini (Moderator)\nNjoki Njiraini is a Consultant Clinical Oncologist based at the Kenyatta National Hospital. \nShe has been key in instituting multidisciplinary meetings\, problem oriented research in the department\, and streamlining patient care within the oncology clinics in the public and private sector. \nDr Njiraini holds a Bachelor’s Degree in Medicine and Surgery from the University of Nairobi\, a Master’s Degree in Radiation Oncology from the University of Cape Town\, is a Fellow of the College of Radiation Oncology (FCRO) South Africa and a graduate of the Harvard POETIC Fellowship programme. \n[/vc_column_text]    \n    	\n                	Gallery                \n        \n    \n    [vc_column_text][Best_Wordpress_Gallery id=”2″ gal_title=”Lung Cancer EGFR”] \n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column]    \n    	\n                	Webinar Recording                \n        \n    \n    [/vc_column][/vc_row][vc_row][vc_column][vc_column_text][vc_row][vc_column][vc_message]Dear Guest\, this content is restricted to only KESHO Members.[/vc_message][vc_row_inner][vc_column_inner width="1/3"]    	\n        Access our Membership Page        \n        [/vc_column_inner][vc_column_inner width="1/3"]    	\n        Fill in the Membership Form        \n        [/vc_column_inner][vc_column_inner width="1/3"]    	\n        Access Membership Portal        \n        [/vc_column_inner][/vc_row_inner][/vc_column][/vc_row] \n[/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/treatment-of-lung-cancer-with-egfr-mutations/
CATEGORIES:CME 2023,Continuing Medical Education (CME),Webinar Recording Available
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2023/07/Lung-cancer-register-btn.jpg
END:VEVENT
END:VCALENDAR